Accordingly, functional studies are now required to determine the specific outcomes driven by aberrant expression and/or function of each SCF complex member gene and its impact on substrate accumulation to better understand the molecular determinants giving rise to cancer development, which will be critical to develop innovative precision medicine strategies to better combat the disease. The gene discussed is KITLG; the disease is cancer.